168 related articles for article (PubMed ID: 26388613)
1. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas.
Flood A; Mai V; Pfeiffer R; Kahle L; Rosen CJ; Lanza E; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1493-8. PubMed ID: 18559566
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
[TBL] [Abstract][Full Text] [Related]
5. High-risk colorectal adenomas and serum insulin-like growth factors.
Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin-like growth factor II and colorectal adenomas.
Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
[TBL] [Abstract][Full Text] [Related]
8. Circulating insulin-like growth factor-related biomarkers: Correlates and responses to calcium supplementation in colorectal adenoma patients.
Um CY; Fedirko V; Flanders WD; Höflich C; Wirthgen E; Bostick RM
Mol Carcinog; 2017 Sep; 56(9):2127-2134. PubMed ID: 28467661
[TBL] [Abstract][Full Text] [Related]
9. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.
Teramukai S; Rohan T; Lee KY; Eguchi H; Oda T; Kono S
Jpn J Cancer Res; 2002 Nov; 93(11):1187-94. PubMed ID: 12460458
[TBL] [Abstract][Full Text] [Related]
11. [Study on the relations between serum insulin-like growth factor-1, insulin-like growth factor binding protein-3 and colorectal cancer: a meta-analysis].
Duan QH; Wang ZG; Zhu GB; Lu ZX; Shi LY; Nie SF
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):132-4. PubMed ID: 15921617
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study.
Pankaj J; Kumari JR; Kim W; Lee SA
Asian Pac J Cancer Prev; 2015; 16(9):3735-40. PubMed ID: 25987030
[TBL] [Abstract][Full Text] [Related]
13. Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis.
Gong Y; Zhang B; Liao Y; Tang Y; Mai C; Chen T; Tang H
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420208
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
15. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
Li L; Yu H; Schumacher F; Casey G; Witte JS
Cancer Causes Control; 2003 Oct; 14(8):721-6. PubMed ID: 14674736
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
[TBL] [Abstract][Full Text] [Related]
17. Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer.
Jiang B; Zhang X; Du LL; Wang Y; Liu DB; Han CZ; Jing JX; Zhao XW; Xu XQ
World J Gastroenterol; 2014 Feb; 20(6):1608-13. PubMed ID: 24587638
[TBL] [Abstract][Full Text] [Related]
18. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
19. Insulin-Like Growth Factor Axis and Gestational Diabetes Mellitus: A Longitudinal Study in a Multiracial Cohort.
Zhu Y; Mendola P; Albert PS; Bao W; Hinkle SN; Tsai MY; Zhang C
Diabetes; 2016 Nov; 65(11):3495-3504. PubMed ID: 27468747
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
